OR52N1

Across TCGA pan-cancer cohorts, OR52N1 Mutation is linked to patient survival in 6 of 34 cancer types, making it a survival-associated OR52N1 data layer compared with 15 for mass-spec protein.

The strongest signal is observed in uterine corpus endometrial carcinoma (UCEC), where higher OR52N1 Mutation is associated with better disease-free survival. In most high-consensus cancer types, elevated OR52N1 expression acts as an unfavorable survival marker, although some lineages such as UCEC show a favorable association.

UCEC, OV, and LUSC are the cancer types where OR52N1 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UCEC	DFS	Median	II,III,IV	1.000	0.436	.012	30	view →
OV	OS	Median	II,III,IV	0.289	0.692	.020	18	view →
LUSC	OS	Median	All	0.321	0.728	.021	9	view →
SARC	OS	Median	All	0.176	0.860	<.001	6	view →
ESCA	OS	Median	III,IV	0.136	0.573	.023	6	view →
SKCM	DFS	Median	II,III,IV	0.087	0.708	<.001	6	view →

Pink = unfavorable, green = favorable. Showing the 6 strongest of 6 lineages.

OR52N1–UCEC (DFS)

Open the UCEC breakdown →